{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:16:56Z","timestamp":1789262216002,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K23888"],"award-info":[{"award-number":["JP19K23888"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07219"],"award-info":[{"award-number":["JP21K07219"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K20054"],"award-info":[{"award-number":["JP16K20054"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07303"],"award-info":[{"award-number":["JP22K07303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K10862"],"award-info":[{"award-number":["JP16K10862"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03784"],"award-info":[{"award-number":["JP19H03784"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03731"],"award-info":[{"award-number":["JP19H03731"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011649","name":"Japan Orthopaedics and Traumatology Foundation","doi-asserted-by":"publisher","award":["365"],"award-info":[{"award-number":["365"]}],"id":[{"id":"10.13039\/501100011649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteosarcoma (OS) is the most common malignant tumor of bone in children and adolescents. Although lung metastasis is a major obstacle to improving the prognosis of OS patients, the underlying mechanism of lung metastasis of OS is poorly understood. Tumor-associated macrophages (TAMs) with M2-like characteristics are reportedly associated with lung metastasis and poor prognosis in OS patients. In this study, we investigated the metastasis-associated tumor microenvironment (TME) in orthotopic OS tumor models with non-metastatic and metastatic OS cells. Non-metastatic and metastatic tumor cells derived from mouse OS (Dunn and LM8) and human OS (HOS and 143B) were used to analyze the TME associated with lung metastasis in orthotopic OS tumor models. OS cell\u2013derived secretion factors were identified by cytokine array and enzyme-linked immunosorbent assay (ELISA). Orthotopic tumor models with metastatic LM8 and 143B cells were analyzed to evaluate the therapeutic potential of a neutralizing antibody in the development of primary and metastatic tumors. Metastatic OS cells developed metastatic tumors with infiltration of M2-like TAMs in the lungs. Cytokine array and ELISA demonstrated that metastatic mouse and human OS cells commonly secreted CCL2, which was partially encapsulated in extracellular vesicles. In vivo experiments demonstrated that while primary tumor growth was unaffected, administration of CCL2-neutralizing antibody led to a significant suppression of lung metastasis and infiltration of M2-like TAMs in the lung tissue. Our results suggest that CCL2 plays a crucial role in promoting the lung metastasis of OS cells via accumulation of M2-like TAMs.<\/jats:p>","DOI":"10.1007\/s00262-025-04051-x","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:28:15Z","timestamp":1746786495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Osteosarcoma cell\u2013derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages"],"prefix":"10.1007","volume":"74","author":[{"given":"Hiroya","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Demiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Uotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Hasei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kunisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"4051_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/ijc.33673","volume":"149","author":"GA Rojas","year":"2021","unstructured":"Rojas GA, Hubbard AK, Diessner BJ, Ribeiro KB, Spector LG (2021) International trends in incidence of osteosarcoma (1988\u20132012). Int J Cancer 149:1044\u20131053. https:\/\/doi.org\/10.1002\/ijc.33673","journal-title":"Int J Cancer"},{"key":"4051_CR2","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","volume":"385","author":"PS Meltzer","year":"2021","unstructured":"Meltzer PS, Helman LJ (2021) New horizons in the treatment of osteosarcoma. N Engl J Med 385:2066\u20132076. https:\/\/doi.org\/10.1056\/NEJMra2103423","journal-title":"N Engl J Med"},{"key":"4051_CR3","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1200\/JCO.2012.43.8598","volume":"31","author":"M Collins","year":"2013","unstructured":"Collins M, Wilhelm M, Conyers R et al (2013) Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. J Clin Oncol 31:2303\u20132312. https:\/\/doi.org\/10.1200\/JCO.2012.43.8598","journal-title":"J Clin Oncol"},{"key":"4051_CR4","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","volume":"21","author":"L Kager","year":"2003","unstructured":"Kager L, Zoubek A, Potschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21:2011\u20132018. https:\/\/doi.org\/10.1200\/JCO.2003.08.132","journal-title":"J Clin Oncol"},{"key":"4051_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"4051_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21:799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5","journal-title":"Nat Rev Drug Discov"},{"key":"4051_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155207","author":"F Cersosimo","year":"2020","unstructured":"Cersosimo F, Lonardi S, Bernardini G, Telfer B, Mandelli GE, Santucci A, Vermi W, Giurisato E (2020) Tumor-associated macrophages in osteosarcoma: from mechanisms to therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21155207","journal-title":"Int J Mol Sci"},{"key":"4051_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051086","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Healey J, Ogura K et al (2021) Role of tumor-associated macrophages in sarcomas. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13051086","journal-title":"Cancers (Basel)"},{"key":"4051_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","volume":"49","author":"Y Gao","year":"2019","unstructured":"Gao Y, Bado I, Wang H, Zhang W, Rosen JM, Zhang XH (2019) Metastasis organotropism: redefining the congenial soil. Dev Cell 49:375\u2013391. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.012","journal-title":"Dev Cell"},{"key":"4051_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X (2016) Characteristics and significance of the pre-metastatic Niche. Cancer Cell 30:668\u2013681. https:\/\/doi.org\/10.1016\/j.ccell.2016.09.011","journal-title":"Cancer Cell"},{"key":"4051_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D (2023) Immune determinants of the pre-metastatic niche. Cancer Cell 41:546\u2013572. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.018","journal-title":"Cancer Cell"},{"key":"4051_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, Dror S, Kenific CM, Lyden D (2019) Exosome-mediated metastasis: communication from a distance. Dev Cell 49:347\u2013360. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.011","journal-title":"Dev Cell"},{"key":"4051_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12125","volume":"10","author":"F Urabe","year":"2021","unstructured":"Urabe F, Patil K, Ramm GA, Ochiya T, Soekmadji C (2021) Extracellular vesicles in the development of organ-specific metastasis. J Extracell Vesicles 10:e12125. https:\/\/doi.org\/10.1002\/jev2.12125","journal-title":"J Extracell Vesicles"},{"key":"4051_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1158\/1078-0432.CCR-16-0290","volume":"23","author":"L Delespaul","year":"2017","unstructured":"Delespaul L, Lesluyes T, Perot G et al (2017) Recurrent TRIO fusion in nontranslocation-related sarcomas. Clin Cancer Res 23:857\u2013867. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0290","journal-title":"Clin Cancer Res"},{"key":"4051_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejca.2015.12.027","volume":"57","author":"T Lesluyes","year":"2016","unstructured":"Lesluyes T, Perot G, Largeau MR et al (2016) RNA sequencing validation of the Complexity INdex in SARComas prognostic signature. Eur J Cancer 57:104\u2013111. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.027","journal-title":"Eur J Cancer"},{"key":"4051_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A (2014) IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 9:e96801. https:\/\/doi.org\/10.1371\/journal.pone.0096801","journal-title":"PLoS ONE"},{"key":"4051_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/(sici)1097-0215(19980504)76:3<418::aid-ijc21>3.0.co;2-5","volume":"76","author":"T Asai","year":"1998","unstructured":"Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S, Yoshikawa H (1998) Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76:418\u2013422. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19980504)76:3%3c418::aid-ijc21%3e3.0.co;2-5","journal-title":"Int J Cancer"},{"key":"4051_CR18","doi-asserted-by":"publisher","first-page":"29469","DOI":"10.18632\/oncotarget.5177","volume":"6","author":"L Ren","year":"2015","unstructured":"Ren L, Mendoza A, Zhu J et al (2015) Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. Oncotarget 6:29469\u201329481. https:\/\/doi.org\/10.18632\/oncotarget.5177","journal-title":"Oncotarget"},{"key":"4051_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23946-8","author":"LG Lima","year":"2021","unstructured":"Lima LG, Ham S, Shin H et al (2021) Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-23946-8","journal-title":"Nat Commun"},{"key":"4051_CR20","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-17-2011","volume":"78","author":"D Shiraishi","year":"2018","unstructured":"Shiraishi D, Fujiwara Y, Horlad H et al (2018) CD163 Is required for protumoral activation of macrophages in human and murine sarcoma. Cancer Res 78:3255\u20133266. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2011","journal-title":"Cancer Res"},{"key":"4051_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2014.10.048","volume":"746","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Sumiyoshi M (2015) Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and\/or G1 arrest in tumor cells. Eur J Pharmacol 746:115\u2013125. https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.048","journal-title":"Eur J Pharmacol"},{"key":"4051_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","volume":"20","author":"T Fujiwara","year":"2021","unstructured":"Fujiwara T, Yakoub MA, Chandler A et al (2021) CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol Cancer Ther 20:1388\u20131399. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0591","journal-title":"Mol Cancer Ther"},{"key":"4051_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10585-005-0365-9","volume":"22","author":"HH Luu","year":"2005","unstructured":"Luu HH, Kang Q, Park JK et al (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22:319\u2013329. https:\/\/doi.org\/10.1007\/s10585-005-0365-9","journal-title":"Clin Exp Metastasis"},{"key":"4051_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222\u2013225. https:\/\/doi.org\/10.1038\/nature10138","journal-title":"Nature"},{"key":"4051_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ni1309","volume":"7","author":"NV Serbina","year":"2006","unstructured":"Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311\u2013317. https:\/\/doi.org\/10.1038\/ni1309","journal-title":"Nat Immunol"},{"key":"4051_CR26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1631\/jzus.B1700003","volume":"18","author":"YL Zhao","year":"2017","unstructured":"Zhao YL, Tian PX, Han F, Zheng J, Xia XX, Xue WJ, Ding XM, Ding CG (2017) Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. J Zhejiang Univ Sci B 18:1055\u20131063. https:\/\/doi.org\/10.1631\/jzus.B1700003","journal-title":"J Zhejiang Univ Sci B"},{"key":"4051_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2172-14-6","volume":"14","author":"C Wang","year":"2013","unstructured":"Wang C, Yu X, Cao Q et al (2013) Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol 14:6. https:\/\/doi.org\/10.1186\/1471-2172-14-6","journal-title":"BMC Immunol"},{"key":"4051_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A (2023) The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol 20:714\u2013738. https:\/\/doi.org\/10.1038\/s41423-023-01013-0","journal-title":"Cell Mol Immunol"},{"key":"4051_CR29","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/0008-5472.CAN-18-3604","volume":"79","author":"F Li","year":"2019","unstructured":"Li F, Kitajima S, Kohno S et al (2019) Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion. Cancer Res 79:3903\u20133915. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3604","journal-title":"Cancer Res"},{"key":"4051_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41419-019-2170-4","volume":"10","author":"J Mu","year":"2019","unstructured":"Mu J, Sun P, Ma Z, Sun P (2019) BRD4 promotes tumor progression and NF-kappaB\/CCL2-dependent tumor-associated macrophage recruitment in GIST. Cell Death Dis 10:935. https:\/\/doi.org\/10.1038\/s41419-019-2170-4","journal-title":"Cell Death Dis"},{"key":"4051_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/1759-7714.12643","volume":"9","author":"L Li","year":"2018","unstructured":"Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D, Guan XY (2018) High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. Thorac Cancer 9:775\u2013784. https:\/\/doi.org\/10.1111\/1759-7714.12643","journal-title":"Thorac Cancer"},{"key":"4051_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M et al (2020) CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer 19:41. https:\/\/doi.org\/10.1186\/s12943-020-01165-x","journal-title":"Mol Cancer"},{"key":"4051_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y et al (2017) Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66:157\u2013167. https:\/\/doi.org\/10.1136\/gutjnl-2015-310514","journal-title":"Gut"},{"key":"4051_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12864-023-09674-x","volume":"24","author":"L Deng","year":"2023","unstructured":"Deng L, Ren J, Li B, Wang Y, Jiang N, Wang Y, Cui H (2023) Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme. BMC Genomics 24:746. https:\/\/doi.org\/10.1186\/s12864-023-09674-x","journal-title":"BMC Genomics"},{"key":"4051_CR35","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1182\/bloodadvances.2024013699","volume":"8","author":"S Kim","year":"2024","unstructured":"Kim S, Jeong H, Ahn HK et al (2024) Increased CCL2\/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC\/BCL2 double-expressor DLBCL. Blood Adv 8:5773\u20135788. https:\/\/doi.org\/10.1182\/bloodadvances.2024013699","journal-title":"Blood Adv"},{"key":"4051_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.735277","volume":"11","author":"CW Lee","year":"2021","unstructured":"Lee CW, Chiang YC, Yu PA et al (2021) A role of CXCL1 drives osteosarcoma lung metastasis via VCAM-1 production. Front Oncol 11:735277. https:\/\/doi.org\/10.3389\/fonc.2021.735277","journal-title":"Front Oncol"},{"key":"4051_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113751","volume":"43","author":"C Deng","year":"2024","unstructured":"Deng C, Xu Y, Chen H et al (2024) Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs. Cell Rep 43:113751. https:\/\/doi.org\/10.1016\/j.celrep.2024.113751","journal-title":"Cell Rep"},{"key":"4051_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99791","author":"AC Gross","year":"2018","unstructured":"Gross AC, Cam H, Phelps DA et al (2018) IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.99791","journal-title":"JCI Insight"},{"key":"4051_CR39","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1038\/s41598-018-27190-x","volume":"8","author":"W Fitzgerald","year":"2018","unstructured":"Fitzgerald W, Freeman ML, Lederman MM, Vasilieva E, Romero R, Margolis L (2018) A system of cytokines encapsulated in extracellular vesicles. Sci Rep 8:8973. https:\/\/doi.org\/10.1038\/s41598-018-27190-x","journal-title":"Sci Rep"},{"key":"4051_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.01.004","volume":"67","author":"RJ Lobb","year":"2017","unstructured":"Lobb RJ, Lima LG, M\u00f6ller A (2017) Exosomes: key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol 67:3\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2017.01.004","journal-title":"Semin Cell Dev Biol"},{"key":"4051_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR et al (2017) Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer 17:302\u2013317. https:\/\/doi.org\/10.1038\/nrc.2017.6","journal-title":"Nat Rev Cancer"},{"key":"4051_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","volume":"18","author":"Y Guo","year":"2019","unstructured":"Guo Y, Ji X, Liu J et al (2019) Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer 18:39. https:\/\/doi.org\/10.1186\/s12943-019-0995-1","journal-title":"Mol Cancer"},{"key":"4051_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.667109","volume":"11","author":"Y Araki","year":"2021","unstructured":"Araki Y, Aiba H, Yoshida T et al (2021) Osteosarcoma-derived small extracellular vesicles enhance tumor metastasis and suppress osteoclastogenesis by miR-146a-5p. Front Oncol 11:667109. https:\/\/doi.org\/10.3389\/fonc.2021.667109","journal-title":"Front Oncol"},{"key":"4051_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155451","author":"A Mazumdar","year":"2020","unstructured":"Mazumdar A, Urdinez J, Boro A, Migliavacca J, Arlt MJE, Muff R, Fuchs B, Snedeker JG, Gvozdenovic A (2020) Osteosarcoma-derived extracellular vesicles induce lung fibroblast reprogramming. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21155451","journal-title":"Int J Mol Sci"},{"key":"4051_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113457","author":"A Mazumdar","year":"2020","unstructured":"Mazumdar A, Urdinez J, Boro A et al (2020) Exploring the role of osteosarcoma-derived extracellular vesicles in pre-metastatic niche formation and metastasis in the 143-B xenograft mouse osteosarcoma model. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12113457","journal-title":"Cancers (Basel)"},{"key":"4051_CR46","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","volume":"192","author":"E Sierra-Filardi","year":"2014","unstructured":"Sierra-Filardi E, Nieto C, Dominguez-Soto A et al (2014) CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile. J Immunol 192:3858\u20133867. https:\/\/doi.org\/10.4049\/jimmunol.1302821","journal-title":"J Immunol"},{"key":"4051_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052379","author":"L Deng","year":"2023","unstructured":"Deng L, Jian Z, Xu T, Li F, Deng H, Zhou Y, Lai S, Xu Z, Zhu L (2023) Macrophage polarization: an important candidate regulator for lung diseases. Molecules. https:\/\/doi.org\/10.3390\/molecules28052379","journal-title":"Molecules"},{"key":"4051_CR48","doi-asserted-by":"publisher","first-page":"1747677","DOI":"10.1080\/2162402X.2020.1747677","volume":"9","author":"K Wolf-Dennen","year":"2020","unstructured":"Wolf-Dennen K, Gordon N, Kleinerman ES (2020) Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions. Oncoimmunology 9:1747677. https:\/\/doi.org\/10.1080\/2162402X.2020.1747677","journal-title":"Oncoimmunology"},{"key":"4051_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300577","volume":"8","author":"KH Griffin","year":"2024","unstructured":"Griffin KH, Mizenko RR, Arun V, Carney RP, Leach JK (2024) Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro-Tumorigenic Macrophage Phenotypes. Adv Biol (Weinh) 8:e2300577. https:\/\/doi.org\/10.1002\/adbi.202300577","journal-title":"Adv Biol (Weinh)"},{"key":"4051_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arcmed.2020.10.018","volume":"52","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Wang L, Wu C, Huang L, Ruan Y, Xue W (2021) Tumor-derived exosomes induced M2 macrophage polarization and promoted the metastasis of osteosarcoma cells through tim-3. Arch Med Res 52:200\u2013210. https:\/\/doi.org\/10.1016\/j.arcmed.2020.10.018","journal-title":"Arch Med Res"},{"key":"4051_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2023.106494","volume":"166","author":"C Li","year":"2024","unstructured":"Li C, Xiang F, Gong Y, Fu Y, Chen G, Wang Z, Li Z, Wei D (2024) Tumor-derived microparticles promoted M2-like macrophages polarization to stimulate osteosarcoma progression. Int J Biochem Cell Biol 166:106494. https:\/\/doi.org\/10.1016\/j.biocel.2023.106494","journal-title":"Int J Biochem Cell Biol"},{"key":"4051_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771210","volume":"12","author":"L Fei","year":"2021","unstructured":"Fei L, Ren X, Yu H, Zhan Y (2021) Targeting the CCL2\/CCR2 Axis in cancer immunotherapy: One stone, three birds? Front Immunol 12:771210. https:\/\/doi.org\/10.3389\/fimmu.2021.771210","journal-title":"Front Immunol"},{"key":"4051_CR53","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","volume":"3","author":"MM Tu","year":"2020","unstructured":"Tu MM, Abdel-Hafiz HA, Jones RT et al (2020) Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Commun Biol 3:720. https:\/\/doi.org\/10.1038\/s42003-020-01441-y","journal-title":"Commun Biol"},{"key":"4051_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12935-022-02763-z","volume":"22","author":"JJ Zhang","year":"2022","unstructured":"Zhang JJ, Liu W, Xing GZ, Xiang L, Zheng WM, Ma ZL (2022) Role of CC-chemokine ligand 2 in gynecological cancer. Cancer Cell Int 22:361. https:\/\/doi.org\/10.1186\/s12935-022-02763-z","journal-title":"Cancer Cell Int"},{"key":"4051_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168530","author":"S Kadomoto","year":"2021","unstructured":"Kadomoto S, Izumi K, Mizokami A (2021) Roles of CCL2-CCR2 axis in the tumor microenvironment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168530","journal-title":"Int J Mol Sci"},{"key":"4051_CR56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12943-024-02161-1","volume":"23","author":"Y Guan","year":"2024","unstructured":"Guan Y, Zhang W, Mao Y, Li S (2024) Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment. Mol Cancer 23:246. https:\/\/doi.org\/10.1186\/s12943-024-02161-1","journal-title":"Mol Cancer"},{"key":"4051_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.talanta.2018.05.011","volume":"188","author":"L Wang","year":"2018","unstructured":"Wang L, Li P, Xiao X, Li J, Li J, Yang HH, Tan W (2018) Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging. Talanta 188:66\u201373. https:\/\/doi.org\/10.1016\/j.talanta.2018.05.011","journal-title":"Talanta"},{"key":"4051_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189033","volume":"1879","author":"S Li","year":"2024","unstructured":"Li S, Kang Y, Zeng Y (2024) Targeting tumor and bone microenvironment: novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis. Biochim Biophys Acta Rev Cancer 1879:189033. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189033","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4051_CR59","doi-asserted-by":"publisher","first-page":"1002742","DOI":"10.3389\/fimmu.2022.1002742","volume":"13","author":"X Gao","year":"2022","unstructured":"Gao X, Gao B, Li S (2022) Extracellular vesicles: a new diagnostic biomarker and targeted drug in osteosarcoma. Front Immunol 13:1002742. https:\/\/doi.org\/10.3389\/fimmu.2022.1002742","journal-title":"Front Immunol"},{"key":"4051_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300882","volume":"12","author":"Z Chen","year":"2023","unstructured":"Chen Z, Yue Z, Yang K, Shen C, Cheng Z, Zhou X, Li S (2023) Four ounces can move a thousand pounds: the enormous value of nanomaterials in tumor immunotherapy. Adv Healthc Mater 12:e2300882. https:\/\/doi.org\/10.1002\/adhm.202300882","journal-title":"Adv Healthc Mater"},{"key":"4051_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-023-01797-9","volume":"22","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li S (2023) Nanomaterials in tumor immunotherapy: new strategies and challenges. Mol Cancer 22:94. https:\/\/doi.org\/10.1186\/s12943-023-01797-9","journal-title":"Mol Cancer"},{"key":"4051_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123159","volume":"230","author":"Y Kang","year":"2023","unstructured":"Kang Y, Li S (2023) Nanomaterials: breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol 230:123159. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123159","journal-title":"Int J Biol Macromol"},{"key":"4051_CR63","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12951-022-01692-3","volume":"20","author":"Z Chen","year":"2022","unstructured":"Chen Z, Yue Z, Yang K, Li S (2022) Nanomaterials: small particles show huge possibilities for cancer immunotherapy. J Nanobiotechnology 20:484. https:\/\/doi.org\/10.1186\/s12951-022-01692-3","journal-title":"J Nanobiotechnology"},{"key":"4051_CR64","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y (2016) Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 10:7738\u20137748. https:\/\/doi.org\/10.1021\/acsnano.6b03148","journal-title":"ACS Nano"},{"key":"4051_CR65","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","volume":"22","author":"T Yin","year":"2022","unstructured":"Yin T, Fan Q, Hu F et al (2022) Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity. Nano Lett 22:6606\u20136614. https:\/\/doi.org\/10.1021\/acs.nanolett.2c01863","journal-title":"Nano Lett"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04051-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:15:42Z","timestamp":1749881742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04051-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4051"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04051-x","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"193"}}